865 top medical experts on Peripheral T-Cell Lymphoma across 34 countries and 34 U.S. states, including 822 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Peripheral T-Cell Lymphoma: A group of malignant lymphomas thought to derive from peripheral T-lymphocytes in lymph nodes and other nonlymphoid sites. They include a broad spectrum of lymphocyte morphology, but in all instances express T-cell markers admixed with epithelioid histiocytes, plasma cells, and eosinophils. Although markedly similar to large-cell immunoblastic lymphoma (lymphoma, large-cell, immunoblastic), this group's unique features warrant separate treatment.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): T-Cell Lymphoma (2,298).
  4. Clinical Trials ClinicalTrials.gov : at least 515 including 42 Active, 191 Completed, 119 Recruiting


  

        

                    


    Computing Expert Listing ...

);